Novo Holdings A/S’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Novo Holdings A/S’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-53,300	Closed	-$5.17M	–	57
2021 Q2	$5.17M	Sell	53,300 -75,000	-58%	-$6.09M	0.23%	49
2021 Q1	$8.77M	Buy	128,300 +45,200	+54%	+$3.66M	0.36%	35
2020 Q4	$7.12M	Sell	83,100 -1,500	-2%	-$127K	0.31%	39
2020 Q3	$5.5M	Hold	84,600	–	–	0.27%	38
2020 Q2	$6.18M	Buy	84,600 +30,500	+56%	+$1.62M	0.4%	30
2020 Q1	$1.84M	Buy	54,100 +18,200	+51%	+$832K	0.12%	29
2019 Q4	$1.95M	Hold	35,900	–	–	0.13%	28
2019 Q3	$1.5M	Buy	+35,900	New	+$1.52M	0.26%	27

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Novo Holdings A/S's BHVN Position: Q3 2021 in Review

Novo Holdings A/S sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2021, closing a stake of 53,300 shares — an estimated $5.17M sold.

Novo Holdings A/S first reported a position in BHVN in Q3 2019 and held it in 8 quarters. The position peaked at $8.77M in Q1 2021. 249 funds tracked by Wall St. Rank hold BHVN as of Q3 2021.

Novo Holdings A/S reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2021 after selling out during the quarter.
Novo Holdings A/S sold 53,300 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2021, an estimated $5.17M.
Novo Holdings A/S first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019 and held it in 8 quarters.
Novo Holdings A/S's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $8.77M in Q1 2021.
249 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2021.

Based on Novo Holdings A/S's 13F filing for Q3 2021, filed 15 Nov 2021.